Updated applications of Ultrasound in Uterine Cervical Cancer

Hsiao, Yi‐Hsuan; Yang, Shun‐Fa; Chen, Yahui; Chen, Tze-Ho; Tsai, Horng‐Der; Chou, Ming-Chih; Chou, Pan-Hsin

doi:10.7150/jca.49479

Cited by 9 publications

(5 citation statements)

References 47 publications

(85 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Multiple researchers have examined the efficacy of using ultrasound (US) for the insertion of applicators and brachytherapy treatment for cervical cancer [90,91]. However, there is currently no established methodology for this specific purpose.…”

Section: Discussionmentioning

confidence: 99%

Integration of Ultrasound in Image-Guided Adaptive Brachytherapy in Cancer of the Uterine Cervix

Manea,

Chitoran,

Rotaru

et al. 2024

Bioengineering

View full text Add to dashboard Cite

Cervical cancer continues to be a public health concern, as it remains the second most common cancer despite screening programs. It is the third most common cause of cancer-related death for women, and the majority of cases happen in developing nations. The standard treatment for locally advanced cervical cancer involves the use of external beam radiation therapy, along with concurrent chemotherapy, followed by an image-guided adaptive brachytherapy (IGABT) boost. The five-year relative survival rate for European women diagnosed with cervical cancer was 62% between 2000 and 2007. Updated cervical cancer treatment guidelines based on IGABT have been developed by the Gynecological working group, which is composed of the Group Européen de Curiethérapie–European Society for Therapeutic Radiology and Oncology. The therapeutic strategy makes use of three-dimensional imaging, which can be tailored to the target volume and at-risk organs through the use of computed tomography or magnetic resonance imaging. Under anaesthesia, the brachytherapy implantation is carried out. Ultrasonography is utilised to assess the depth of the uterine cavity and to facilitate the dilation of the uterine canal during the application insertion. In this study, we examine data from the international literature regarding the application of ultrasound in cervical cancer brachytherapy.

show abstract

Section: Discussionmentioning

confidence: 99%

Integration of Ultrasound in Image-Guided Adaptive Brachytherapy in Cancer of the Uterine Cervix

Manea,

Chitoran,

Rotaru

et al. 2024

Bioengineering

View full text Add to dashboard Cite

show abstract

“…These factors may result in discordant findings between 3T MRI and pathologic examination in terms of residual tumors. Advanced ultrasonography with 3D and color Doppler display as well as transvaginal elastography also may be useful to evaluate early cervical cancer [ 27 ].…”

Section: Discussionmentioning

confidence: 99%

Utility of 3T MRI in Women with IB1 Cervical Cancer in Determining the Necessity of Less Invasive Surgery

Jeong

Park

Choi

et al. 2022

Cancers

View full text Add to dashboard Cite

Purpose: Cervical cancer that is invisible on magnetic resonance imaging (MRI) may suggest lower tumor burden than physical examination. Recently, 3 tesla (3T) MRI has been widely used prior to surgery because of its higher resolution than 1.5T MRI. The aim was to retrospectively evaluate the utility of 3T MRI in women with early cervical cancer in determining the necessity of less invasive surgery. Materials and methods: Between January 2010 and December 2015, a total of 342 women with FIGO stage IB1 cervical cancer underwent 3T MRI prior to radical hysterectomy, vaginectomy, and lymph node dissection. These patients were classified into cancer-invisible (n = 105) and cancer-visible (n = 237) groups based on the 3T MRI findings. These groups were compared regarding pathologic parameters and long-term survival rates. Results: The cancer sizes of the cancer-invisible versus cancer-visible groups were 11.5 ± 12.2 mm versus 30.1 ± 16.2 mm, respectively (p < 0.001). The depths of stromal invasion in these groups were 20.5 ± 23.6% versus 63.5 ± 31.2%, respectively (p < 0.001). Parametrial invasion was 0% (0/105) in the cancer-invisible group and 21.5% (51/237) in the cancer-visible group (odds ratio = 58.3, p < 0.001). Lymph node metastasis and lymphovascular space invasion were 5.9% (6/105) versus 26.6% (63/237) (5.8, p < 0.001) and 11.7% (12/105) versus 40.1% (95/237) (5.1, p < 0.001), respectively. Recurrence-free and overall 5-year survival rates were 99.0% (104/105) versus 76.8% (182/237) (p < 0.001) and 98.1% (103/105) versus 87.8% (208/237) (p = 0.003), respectively. Conclusions: 3T MRI can play a great role in determining the necessity of parametrectomy in women with IB1 cervical cancer. Therefore, invisible cervical cancer on 3T MRI will be a good indicator for less invasive surgery.

show abstract

“…Additionally, ultrasound might be helpful in prediction of the cervical cancer response to radiotherapy, chemotherapy or neoadjuvant chemotherapy (via monitoring tumor vascularity by Doppler as most of cervical carcinomas are hypervascular). Ultrasound has a limited role in determination of metastatic lymphadenopathy [ 7 , 15 ].…”

Section: Imagingmentioning

confidence: 99%

Recent Imaging Updates and Advances in Gynecologic Malignancies

Daoud

Sardana

Stanietzky

et al. 2022

Cancers

View full text Add to dashboard Cite

Gynecologic malignancies are among the most common cancers in women worldwide and account for significant morbidity and mortality. Management and consequently overall patient survival is reliant upon early detection, accurate staging and early detection of any recurrence. Ultrasound, Computed Tomography (CT), Magnetic resonance imaging (MRI) and Positron Emission Tomography-Computed Tomography (PET-CT) play an essential role in the detection, characterization, staging and restaging of the most common gynecologic malignancies, namely the cervical, endometrial and ovarian malignancies. Recent advances in imaging including functional MRI, hybrid imaging with Positron Emission Tomography (PET/MRI) contribute even more to lesion specification and overall role of imaging in gynecologic malignancies. Radiomics is a neoteric approach which aspires to enhance decision support by extracting quantitative information from radiological imaging.

show abstract

Updated applications of Ultrasound in Uterine Cervical Cancer

Cited by 9 publications

References 47 publications

Integration of Ultrasound in Image-Guided Adaptive Brachytherapy in Cancer of the Uterine Cervix

Integration of Ultrasound in Image-Guided Adaptive Brachytherapy in Cancer of the Uterine Cervix

Utility of 3T MRI in Women with IB1 Cervical Cancer in Determining the Necessity of Less Invasive Surgery

Recent Imaging Updates and Advances in Gynecologic Malignancies

Contact Info

Product

Resources

About